Nikolai Enggård

Nikolai Enggård is an accomplished finance professional with extensive experience in financial planning and analysis, particularly within Novozymes, where leadership roles include Director, Head of Group Financial Planning & Analysis, and Finance Director & Divisional CFO. With a proven track record of optimizing shareholder value through strategic financial management, Nikolai Enggård has overseen financial operations for divisions generating over 1 billion USD in sales. Additionally, Nikolai Enggård has led performance management initiatives, managed talent development programs, and collaborated closely with senior leadership to enhance corporate financial transparency and efficiency. Educational qualifications include a Master's in Finance and Strategic Management from Copenhagen Business School and an MBA from Brandeis International Business School.